Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (56 ops.)
Latest filing published 20 Oct 2025 for LAVA Therapeutics NV, €879k. Read the official filing
Filing timeline
BuySaleGilde Healthcare IV U.A. Cooperatieve
Insider track record
Disclosed buys
1
Disclosed sells
56
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gilde Healthcare IV U.A. Cooperatieve: trading record in brief
Gilde Healthcare IV U.A. Cooperatieve is a declared insider at 2 companies; the most frequent names are Inari Medical, Inc. and LAVA Therapeutics NV. Between 27 May 2020 and 16 October 2025, the trades on record add up to 58 filings.
The open-market side counts 1 purchase for €5.9M alongside 56 sales for €119.1M. On balance, insiders were net sellers of €113.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2025 alone, the filings show no purchases and 3 sales.
Most recently, on 20 October 2025, the filings show an open-market sale worth €879k in LAVA Therapeutics NV. The last insider purchase was made public on 27 May 2020, 2,338 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gilde Healthcare IV U.A. Cooperatieve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations58 total
690,239 shares@ US$1.4989.6% of flowCommon SharesSEC:0001193125-25-243899:0
47,686 shares@ US$1.546.5% of flowCommon SharesSEC:0001193125-25-240610:0
28,954 shares@ US$1.574.0% of flowCommon SharesSEC:0001193125-25-237275:0
46,365 shares@ US$79.512.4% of flowCommon StockSEC:0000899243-20-035182:0
164,392 shares@ US$80.458.8% of flowCommon StockSEC:0000899243-20-035182:1
42,643 shares@ US$81.362.3% of flowCommon StockSEC:0000899243-20-035182:2
8,926 shares@ US$82.040.5% of flowCommon StockSEC:0000899243-20-035182:3
2,234 shares@ US$83.400.1% of flowCommon StockSEC:0000899243-20-035182:4
1,208 shares@ US$84.270.1% of flowCommon StockSEC:0000899243-20-035182:5
5,852 shares@ US$80.790.3% of flowCommon StockSEC:0000899243-20-035182:6
22,439 shares@ US$81.731.2% of flowCommon StockSEC:0000899243-20-035182:7
8,830 shares@ US$82.640.5% of flowCommon StockSEC:0000899243-20-035182:8
1,947 shares@ US$83.470.1% of flowCommon StockSEC:0000899243-20-035182:9
63,840 shares@ US$70.523.0% of flowCommon StockSEC:0000899243-20-034885:0
110,474 shares@ US$71.535.2% of flowCommon StockSEC:0000899243-20-034885:1
41,878 shares@ US$72.162.0% of flowCommon StockSEC:0000899243-20-034885:2
11,885 shares@ US$70.410.6% of flowCommon StockSEC:0000899243-20-034885:3
13,125 shares@ US$71.730.6% of flowCommon StockSEC:0000899243-20-034885:4
54,257 shares@ US$72.472.6% of flowCommon StockSEC:0000899243-20-034885:5
71,415 shares@ US$73.473.5% of flowCommon StockSEC:0000899243-20-034885:6
44,268 shares@ US$74.532.2% of flowCommon StockSEC:0000899243-20-034885:7
20,754 shares@ US$76.111.0% of flowCommon StockSEC:0000899243-20-034885:8
71,340 shares@ US$77.223.6% of flowCommon StockSEC:0000899243-20-034885:9
98,190 shares@ US$78.215.1% of flowCommon StockSEC:0000899243-20-034885:10
4,880 shares@ US$78.570.3% of flowCommon StockSEC:0000899243-20-034885:11
25 of 58 declarations
